Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Life Sciences|April 27, 2019
CXCL13/CXCR5 signaling axis in cancerMuzammal Hussain, Dickson Adah, Muqddas Tariq, et al.
Pharmacological Research|May 10, 2016
Implications of MDSCs-targeting in lung cancer chemo-immunotherapeuticsDickson Adah, Muzammal Hussain, Limei Qin, et al.
Medical Hypotheses|January 26, 2016
Targeting tumor-associated immune suppression with selective protein kinase A type I (PKAI) inhibitors may enhance cancer immunotherapyMuzammal Hussain, Zahir Shah, Nasir Abbas, et al.
Chemical Biology & Drug Design|September 3, 2016
Synthesis and biological evaluation of novel dasatinib analogues as potent DDR1 and DDR2 kinase inhibitorsLu Liu, Muzammal Hussain, Jinfeng Luo, et al.
The Journal of Organic Chemistry|July 22, 2020
Design, Synthesis, and Resolution of Spirocyclic Bisoxindole-Based C2-Symmetric DiolsGuodong Sun, Zhongqing Wang, Zhonghua Luo, et al.
Bioorganic & Medicinal Chemistry|January 14, 2017
Discovery of hepatitis B virus capsid assembly inhibitors leading to a heteroaryldihydropyrimidine based clinical candidate (GLS4)Qingyun Ren, Xinchang Liu, Zhonghua Luo, et al.
Expert Opinion on Therapeutic Targets|November 18, 2017
ATAD2 in cancer: a pharmacologically challenging but tractable targetMuzammal Hussain, Yang Zhou, Yu Song, et al.
Antiviral Research|November 14, 2017
Design, synthesis, and biological evaluation of novel 7-deazapurine nucleoside derivatives as potential anti-dengue virus agentsCai Lin, Jianchen Yu, Muzammal Hussain, et al.
Pharmacological Research|May 31, 2016
Skp1: Implications in cancer and SCF-oriented anti-cancer drug discoveryMuzammal Hussain, Yongzhi Lu, Yong-Qiang Liu, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2015
Synthesis and biological evaluation of 3,5-disubstituted-4-alkynylisoxozales as a novel class of HSP90 inhibitorsJian Sun, Cai Lin, Xiaochu Qin, et al.
Pageof 5